JPRN-UMIN000049573
Completed
未知
Research on Clinical Practice for Generalized Anxiety Disorder (GAD) Using the General Public as Subjects - Research on Clinical Practice for Generalized Anxiety Disorder (GAD) Using the General Public as Subjects
Viatris Pharmaceuticals Japan Inc.0 sites20,000 target enrollmentNovember 21, 2022
ConditionsGeneralized anxiety disorder
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Generalized anxiety disorder
- Sponsor
- Viatris Pharmaceuticals Japan Inc.
- Enrollment
- 20000
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •There are no exclusion criteria for this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A CLINICAL TRIAL TO STUDY THE EFFECTS OF BRAHMI (Bacopa monnieri) IN PATIENTS WITH Generalized Anxiety DisorderCTRI/2016/04/006819GOVT AKHANDANAND AYRVED COLLEGEAHMEDABAD AND MANIBEN AYURVED HOSPITAL AHMEDABAD34
Completed
Not Applicable
Investigating the effectiveness of Quranic treatment of generalized anxiety disorder on anxiety levelsIRCT20230123057186N1Islamic Azad University30
Recruiting
Phase 1
Study on the effect and mechanism of treating anxiety and depression in elderly patients with hypertensioITMCTR2000003784Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Not yet recruiting
Phase 1
A clinical study on the treatment of generalized anxiety disorder with theITMCTR2000004129West China Hospital, Sichuan University
Active, not recruiting
Not Applicable
Prise en charge pharmacologique de l’anxiété et de la douleur chez les patients qui souffrent en situation d’urgence traumatique préhospitalière : étude randomisée contrôlée en double-aveugle.douleur en situation d’urgence traumatique préhospitalièreMedDRA version: 12.0Level: LLTClassification code 10065016Term: Post-traumatic painEUCTR2009-015529-35-FRCHU TOULOUSE